Is CNGFF or MRK a better dividend investment in 2026?

CNGFF currently yields 4268.94% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: CNGFF offers higher current income.

What is the dividend yield difference between CNGFF and MRK?

CNGFF has a forward dividend yield of 4268.94% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 4266.18 percentage points.

Home › Compare › CNGFF vs MRK

CNGFF vs MRK: Dividend Comparison 2026

CNGFF yields 4268.94% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CNGFF wins by $13449187956196.47M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CNGFF

● Live price

4268.94%

Share price

$0.05

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$13449187956196.53M

Annual income

$12,856,742,566,237,570,000.00

Full CNGFF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — CNGFF vs MRK

📍 CNGFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CNGFF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CNGFF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CNGFF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CNGFF

Annual income on $10K today (after 15% tax)

$362,860.19/yr

After 10yr DRIP, annual income (after tax)

$10,928,231,181,301,934,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, CNGFF beats the other by $10,928,231,181,301,926,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CNGFF + MRK for your $10,000?

CNGFF: 50%MRK: 50%

100% MRK50/50100% CNGFF

Portfolio after 10yr

$6724593978098.29M

Annual income

$6,428,371,283,118,790,000.00/yr

Blended yield

95.59%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CNGFF

No analyst data

Altman Z

-1.9

Piotroski

3/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CNGFF buys

MRK buys

No recent congressional trades found for CNGFF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCNGFFMRK

Forward yield	4268.94% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$13449187956196.53M ✓	$56.8K
Annual income after 10y	$12,856,742,566,237,570,000.00 ✓	$9,798.13
Total dividends collected	$13408878326277.82M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CNGFF vs MRK ($10,000, DRIP)

Year	CNGFF Portfolio	CNGFF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$437,594	$426,894.34	$11,206	$366.19	+$426.4K → CNGFF
2	$17,926,782	$17,458,556.09	$12,650	$502.35	+$17.91M → CNGFF
3	$687,610,502	$668,428,845.31	$14,407	$694.19	+$687.60M → CNGFF
4	$24,697,108,999	$23,961,365,762.14	$16,585	$967.82	+$24697.09M → CNGFF
5	$830,750,611,305	$804,324,704,675.98	$19,342	$1,363.89	+$830750.59M → CNGFF
6	$26,174,440,164,056	$25,285,537,009,959.18	$22,913	$1,947.19	+$26174440.14M → CNGFF
7	$772,558,824,553,735	$744,552,173,578,194.90	$27,662	$2,823.89	+$772558824.53M → CNGFF
8	$21,364,986,227,501,996	$20,538,348,285,229,500.00	$34,159	$4,173.35	+$21364986227.47M → CNGFF
9	$553,687,280,335,478,660	$530,826,745,072,051,460.00	$43,337	$6,308.80	+$553687280335.44M → CNGFF
10	$13,449,187,956,196,532,000	$12,856,742,566,237,570,000.00	$56,776	$9,798.13	+$13449187956196.47M → CNGFF

CNGFF vs MRK: Complete Analysis 2026

CNGFF — Stock

Change Financial Limited, a fintech company, offers payment-as-a-service solutions in South East Asia, Oceania, Latin America, the United States, and internationally. It provides Vertexon PaaS, a physical and virtual card issuing and transaction processing platform; and PaySim, payment testing solution. The company was formerly known as ChimpChange Limited and changed its name to Change Financial Limited in July 2017. Change Financial Limited was incorporated in 2011 and is based in Brisbane, Australia.

Full CNGFF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this CNGFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CNGFF vs SCHD CNGFF vs JEPI CNGFF vs O CNGFF vs KO CNGFF vs MAIN CNGFF vs JNJ CNGFF vs ABBV CNGFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.